TITLE

Why don't we initiate more large simple randomized controlled trials?

AUTHOR(S)
Wright, James M.
PUB. DATE
November 2003
SOURCE
CMAJ: Canadian Medical Association Journal;11/25/2003, Vol. 169 Issue 11, p1170
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on the introduction of a class of drugs for the treatment of arthritis, the COX-2 selective nonsteroidal anti-inflammatory drugs (NSAID). Dilemma created by the use of NSAID; Model for drug evaluation in Canada.
ACCESSION #
11399648

 

Related Articles

  • Gastroduodenal Mucosa and Dyspeptic Symptoms in Arthritic Patients during Chronic Nonsteroidal Anti-Inflammatory Drug Use. Larkai, Edwin N.; Smith, J. Lacey; Lidsky, Martin D.; Graham, David Y. // American Journal of Gastroenterology;Nov1987, Vol. 82 Issue 11, p1153 

    Gastroduodenal intolerance is one of the major factors limiting the use of aspirin and other nonsteroidal anti-inflammatory drugs (NSAID) in patients with arthritic conditions. We evaluated the endoscopic appearance of the gastroduodenal mucosa in 65 patients (63 men and two women) taking...

  • Three nonsteroid anti-inflammatory agents for arthritis. Rodman, Morton J. // RN;Sep76, Vol. 39 Issue 9, p16 

    Presents information on three nonsteroid anti-inflammatory agents for arthritis. Characteristics of the drugs; Beneficial effects of the drugs; Response of patients to the drugs.

  • Reactive arthritis. Svenungsson, B. // BMJ: British Medical Journal (International Edition);3/12/94, Vol. 308 Issue 6930, p671 

    Features reactive arthritis and the establishment of the best treatment in Great Britain. Pathophysiology of the disease; Relationship between host and the microbial factors; Treatment of reactive arthritis by the use of non-steroidal anti-inflammatory drugs.

  • Safety and Efficacy of Disease-Modifying Anti-Rheumatic Agents: Focus on the Benefits and Risks of Etanercept. Fleischmann, R.; Iqbal, I.; Nandeshwar, P.; Quiceno, A. // Drug Safety;Feb2002, Vol. 25 Issue 3, p173 

    The traditional approach to the treatment of rheumatoid arthritis (RA) has been the use of nonsteroidal anti-inflammatory drugs usually in combination with a disease-modifying antirheumatic drug (DMARD) such as hydroxychloroquine, gold, sulfasalazine, methotrexate, leflunomide or cyclosporin....

  • Healthcare Resource Utilisation and Costs of Treating NSAID-Associated Gastrointestinal Toxicity: A Multinational Perspective. Chevat, C.; Pena, B.M.; Al, M.J.; Rutten, F.F. // PharmacoEconomics;Aug2001 Supplement 1, Vol. 19 Issue 8, p17 

    Objective: The aim of the study was to perform an economic analysis of a new therapy in 11 countries (Australia, Belgium, Finland, France, Germany, Italy, The Netherlands, Spain, Sweden, Switzerland and the UK) to assess the cost of treating the gastrointestinal (GI) events associated with the...

  • The Burden of Arthritis and Nonsteroidal Anti-Inflammatory Treatment: A European Literature Review. Hunsche, E.; Chancellor, J.V.M.; Bruce, N. // PharmacoEconomics;Aug2001 Supplement 1, Vol. 19 Issue 8, p1 

    The purpose of this literature review is to summarise data available from publications describing the burden of osteoarthritis and rheumatoid arthritis in Europe, and to highlight gaps in the literature. On the basis of extensive literature research, the epidemiology of arthritis, its treatment...

  • The New ARTHRITIS SUPER DRUGS. Loecher, Barbara; Weiss Kiser, Sherry // Prevention;Dec2000, Vol. 52 Issue 12, p130 

    Focuses on the benefits and side effects of COX-2 inhibitors, a group of nonsteroidal anti-inflammatory drugs used for treating arthritis pain. INSET: Save Money, Use Fewer Drugs.

  • Standard creams cut prescribing costs.  // GP: General Practitioner;5/13/2002, p77 

    Reports on the cost-effective use of Algesal cream and Intralgin gel for arthritis. Comparison with the use of Non-Steroid Anti-Inflammatory Drug (NSAID) in treating arthritis; Cost associated with the use of NSAID; Number of patients using Algesal and Intralgin.

  • What to watch for with the new arthritis drugs. White, Sara J.; Williamson, Karin // RN;Feb80, Vol. 43 Issue 2, p31 

    Provides information on non-steroidal anti-inflammatory agents (NSAID) used to treat arthritic patients. Mechanism of action; Negative effects of the drugs; Laboratory tests that are altered by NSAID.

  • Methods for application of topical nonsteroidal anti-inflammatory drugs (TNSAIDS) in clinical trials. Gerecz-Simon, E.; kean, W. F. // Inflammopharmacology;1999, Vol. 7 Issue 3, p329 

    Examines the methods for application of topical non-steroidal anti-inflammatory drugs (TNSAID) in clinical trials of patients with musculoskeletal diseases. Person responsible for the application of TNSAID; Establishment of standard dosage for TNSAID; What to avoid after the application of TNSAID.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics